Overview
Softlogic Holdings is a diversified group spanning retail and telecommunications, healthcare, financial services, information technology, automobiles, and leisure and property. Its portfolio includes Softlogic Life, Asiri Health, ODEL, consumer electronics and supermarket operations, and hotel assets.
The latest results show a clear split: operating performance has improved materially, but finance costs and other below-line items continue to prevent that improvement from reaching shareholders.
Price performance
The share fell 17.4% over three months while the ASPI declined 1.8%, creating a sharp disagreement between operating improvement and market performance. Over one year, however, SHL rose 33.3% against the index's 7.4% gain.
The closing price was LKR 9.90 as at 20 August 2026. It sat at 36.9% of its 52-week range, and 60-day annualised volatility was 20.0% below the company's own one-year level. The three-month decline is therefore notable, but it occurred within a still-positive one-year return.
Valuation
Conventional valuation measures do not support a meaningful equity comparison: P/E and P/B are unavailable because the company is loss-making and has negative book value, while ROE is also unavailable. The diversified-holdings sector medians are 13.48 times P/E and 1.3 times P/B, but SHL cannot be ranked against them on those measures.
Dividend yield is 0.0%, and the supplied data contains no dividend history. The direction of the payout therefore cannot be established, so there is no income argument to offset the balance-sheet impairment.
News and sentiment
Coverage has been unusually heavy: seven company articles appeared in the last 30 days against a baseline of 2.2 per month. Across the wider 90-day window, nine material articles split into six positive, one negative and two neutral reports.
The main developments were the 20 August hotel management agreement with Accor and Pullman rebranding, positive Softlogic Life operating updates, and the 17 August rights issue announcement. The SEC also deferred the proposed trading suspension until 30 June 2027. The rights-related event remains announced rather than confirmed, with no ex-date set.
Financials
For the group quarter ended 30 June 2026, revenue grew 13.4% year-on-year and operating profit grew 77.0% to LKR 4.19 billion. The net loss widened by LKR 149 million to LKR 1.82 billion, showing that stronger trading did not translate into bottom-line recovery. The below-line drag was LKR 6.01 billion.
Gross margin widened from 34.0% to 38.5%, ranking second among nine comparable June quarters. Operating margin widened from 7.9% to 12.3%, also ranking second of nine, while net margin improved from -5.6% to -5.3% but ranked only fourth of nine. These comparisons are like-for-like group filings.
Total equity attributable to owners was negative LKR 71.79 billion and reported net assets per share were negative LKR 51.46. Shares outstanding were 1.40 billion, unchanged from June 2025; the older June 2024 figure was 1.19 billion, so longer-term per-share comparisons are affected by the share-count increase. A 17 August 2026 news report separately described the June-quarter loss as LKR 2.79 billion, so that later reported figure should not be mixed with the filed series above.
Risks
The primary risk is solvency: debt was LKR 66.05 billion against negative owners' equity, producing gearing of -113.9% on the reported measure. Interest cover was only 0.46 times, so operating profit covered less than half of the finance charge.
Liquidity is also strained, with a current ratio of 0.44. The annual cash conversion measure was 1.04 times, so the latest annual operating profit was broadly cash-backed, but this does not remove the group's negative-equity problem. Free cash flow was LKR 4.76 billion, while minority shareholders accounted for -38.9% of reported profit, meaning group earnings and the earnings attributable to SHL owners are not the same pool.
The largest external exposures are financial services and consumer retail, representing 34.3% and 32.9% of reported segment revenue. Easier funding conditions may help the finance businesses, but sector-wide slower lending growth and rising corporate, SME and SOE non-performing loans remain relevant risks. Retail also faces inflation, energy and transport cost pressure.
Outlook
As at 20 August 2026, the next material corporate event is the announced conversion of warrants into shares, declared on 17 August. Its ex-date has not been set; based on the supplied history, the estimated ex-window is 11 September to 3 December 2026. The absence of an issue ratio, price and confirmed date leaves the potential dilution and balance-sheet benefit impossible to assess.
The next filing covers the quarter ending 30 September 2026 and is expected, based on exchange timing, between 7 November 2026 and 5 January 2027. That filing will supersede the June-quarter evidence. The Accor agreement and Softlogic Life growth provide operating positives, but the data cannot yet show whether those benefits will overcome finance costs and restore positive equity.